Top compounds associated with response to AC003002.6


Feature Type Standardized
Nominal ANOVA
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.13 0.001
mRNA CCT036477 CTRPv2 pan-cancer AAC 0.12 0.001
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.18 0.001
mRNA ciclopirox CTRPv2 pan-cancer AAC 0.11 0.001
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.13 0.002
mRNA AA-COCF3 CTRPv2 pan-cancer AAC 0.12 0.002
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.11 0.002
mRNA SKI-II CTRPv2 pan-cancer AAC 0.12 0.003
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.1 0.003
mRNA lovastatin CTRPv2 pan-cancer AAC -0.11 0.004
Download CSV